Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.64 |
| ▸ | NPY1R | P25929 | 6/20 | 0.64 |
| ▸ | NPY2R | P49146 | 4/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.64 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29461999 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL31694494 | 0.99 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29641039 | 0.97 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29641110 | 0.97 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29641042 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL22133073 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL29641040 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL29641130 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL29641095 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL8975469 | 0.94 | NPY4R (0.73) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4422645-A2 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Wave Life Sciences Ltd. (SG) | 2024-09-04 | — | — | EP | disclosed |
| US-20230293624-A1 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION | CORNELL RESEARCH FOUNDATION, INC. (US) | 2023-09-21 | — | — | US | disclosed |
| WO-2023076352-A2 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023075766-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-05-04 | — | — | WO | disclosed |